Benzinga | Aug 5, 2021 08:47AM EDT

Albireo Pharma Q2 EPS $(1.90) Beats $(1.96) Estimate, Sales $2.43M Beat $1.98M Estimate

Albireo Pharma (NASDAQ:ALBO) reported quarterly losses of $(1.90) per share which beat the analyst consensus estimate of $(1.96) by 3.06 percent. This is a 37.68 percent decrease over losses of $(1.38) per share from the same period last year. The company reported quarterly sales of $2.43 million which beat the analyst consensus estimate of $1.98 million by 22.63 percent. This is a 26.99 percent increase over sales of $1.91 million the same period last year.